Biotech Companies Settle Lawsuit Against Columbia Over Lucrative Licensing Deals
Biotechnology companies Genzyme Corp. and Biogen Idec Inc. have settled a lawsuit against Columbia University over patents that have raised $600 million in royalties for the university....To view the full article, register now.
Already a subscriber? Click here to view full article